Event
Microbot Medical receives first international LIBERTY marketing approval
Evidence notes
- Israel became the second jurisdiction, after the U.S., to clear LIBERTY for marketing.
- The AMAR approval supports commercialization in Israel and a Free Sale Certificate for additional submissions.
Company context
Microbot Medical develops LIBERTY, a compact single-use endovascular robotic system designed for remotely operated vascular access and navigation.
Context
- Company
- Microbot Medical
- Segment
- Surgical
- Event type
- Regulatory
- Evidence
- Source linked
- Added to Korthos
- Jun 19, 2026
- Geography
- Hingham, MA · United States